Related references
Note: Only part of the references are listed.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Familial Hypercholesterolaemia in 2020: A Leading Tier 1 Genomic Application
Jing Pang et al.
HEART LUNG AND CIRCULATION (2020)
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action
Katherine A. Wilemon et al.
JAMA CARDIOLOGY (2020)
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
Don P. Wilson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?
Dick C. Chan et al.
CLINICAL CHEMISTRY (2019)
Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry
P. Barton Duell et al.
ATHEROSCLEROSIS (2019)
Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register
Steve E. Humphries et al.
ATHEROSCLEROSIS (2019)
HEART UK consensus statement on Lipoprotein(a): A call to action
Jaimini Cegla et al.
ATHEROSCLEROSIS (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register
S. E. Humphries et al.
ATHEROSCLEROSIS (2018)
Sex Differences in Ischemic Heart Disease Advances, Obstacles, and Next Steps
Niti R. Aggarwal et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data
Steve E. Humphries et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
Sotirios Tsimikas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Sex Differences in Ischemic Heart Disease Advances, Obstacles, and Next Steps
Niti R. Aggarwal et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Antonio J. Vallejo-Vaz et al.
ATHEROSCLEROSIS (2018)
The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data
Uma Ramaswami et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2017)
A Web-Based Registry for Familial Hypercholesterolaemia
Kathryn R. Napier et al.
HEART LUNG AND CIRCULATION (2017)
Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International Collaboration
Matthew I. Bellgard et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome
Almudena Amor-Salamanca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis
Leo E. Akioyamen et al.
BMJ OPEN (2017)
Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry
Stephen M. Amrock et al.
ATHEROSCLEROSIS (2017)
Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United States
Steve Varvel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States Data From the CASCADE-FH Registry
Emil M. deGoma et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions
Katrina L. Ellis et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia 5-Year SAFEHEART Registry Follow-Up
Leopoldo Perez de Isla et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States Data From the CASCADE-FH Registry
Emil M. deGoma et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
Raul D. Santos et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
Anne Langsted et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience
Damon A. Bell et al.
ATHEROSCLEROSIS (2015)
Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia
Dick C. Chan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1-Full Report
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
Gerald F. Watts et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia
Zanfina Ademi et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Lipoprotein(a) Levels in Familial Hypercholesterolemia An Important Predictor of Cardiovascular Disease Independent of the Type of LDL Receptor Mutation
Rodrigo Alonso
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Genetic analysis of familial hypercholesterolaemia in Western Australia
Amanda J. Hooper et al.
ATHEROSCLEROSIS (2012)
Familial hypercholesterolaemia: A model of care for Australasia
Gerald F. Watts et al.
ATHEROSCLEROSIS SUPPLEMENTS (2011)
The American Heart Association's Recommendations for Expanding the Applications of Existing and Future Clinical Registries A Policy Statement From the American Heart Association
Vincent J. Bufalino et al.
CIRCULATION (2011)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing
Brian Starr et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands
MAW Umans-Eckenhausen et al.
LANCET (2001)
Lipoprotein(a) in homozygous familial hypercholesterolemia
HG Kraft et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
